The clinical use and immunologic impact of thrombin in surgery.
about
Soft materials to treat central nervous system injuries: evaluation of the suitability of non-mammalian fibrin gelsUse of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agentsThe effect of human platelet-rich plasma on adipose-derived stem cell proliferation and osteogenic differentiation.Hybrid composites of mesenchymal stem cell sheets, hydroxyapatite, and platelet-rich fibrin granules for bone regeneration in a rabbit calvarial critical-size defect model.The effects of surgicel and bone wax hemostatic agents on bone healing: An experimental studyWound healing and the immune response in swine treated with a hemostatic bandage composed of salmon thrombin and fibrinogen.Platelet activation by collagen provides sustained release of anabolic cytokines.Hemostatic effect and distribution of new rhThrombin formulations in ratsCharacterization of the cytokine profile of platelet rich plasma (PRP) and PRP-induced cell proliferation and migration: Upregulation of matrix metalloproteinase-1 and -9 in HaCaT cellsEfficacy of a topical bovine-derived thrombin solution as a hemostatic agent in a rodent model of hepatic injuryModification of Pulsed Electric Field Conditions Results in Distinct Activation Profiles of Platelet-Rich PlasmaAdvantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in promoting repair of bone defects.Activation of platelet-rich plasma using soluble type I collagen.Topical hemostatic agents in surgery: a surgeon's perspective.Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety.Achieving hemostasis in the surgical field.Topical thrombins: benefits and risks.Clinical use of topical thrombin as a surgical hemostat.Thrombin use in surgery: an evidence-based review of its clinical use.An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis.Platelet-rich plasma stimulated by pulse electric fields: Platelet activation, procoagulant markers, growth factor release and cell proliferation.Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up.Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation.Safety and efficacy of thrombin-JMI: a multidisciplinary expert group consensus.[Gelatin-thrombin matrix-mediated hemostasis: application in tonsillectomy].Patient blood management: use of topical hemostatic and sealant agents.Hemostasis and nanotechnology.A Case of Intraoperative Anaphylaxis Caused by Bovine-Derived Thrombin.Thromboelastographic Clot Characteristics of Autologous Equine Blood Products After Activation by Autologous Thrombin, Bovine Thrombin, or Calcium Chloride.
P2860
Q24622347-4266BC16-BDA7-4B26-9742-0401448FF028Q26861415-228CF986-094A-42C4-B2F8-172C58B034FFQ33722448-2453E5CE-0EDD-46FB-B398-8FBD461D55C4Q33723847-EE49F982-64FE-42FC-A3A6-9D4FCFF04DFDQ33735705-A354BF46-2FAF-4B1C-847F-0D5641278B9FQ35055085-15C571EB-D597-44A8-B46D-F5E2D5F74F66Q35223254-663739F9-2D3D-4558-A41E-6E8CA8791E45Q35620486-B48A2286-7B1C-4104-B1DD-5B10F5BF3595Q35676042-A2122D30-22CA-4F0F-B242-95601C4727CCQ36089539-C62483BF-618A-4140-A2E8-2528C9922FE7Q36111366-7735704D-9B5D-48EA-B868-E93B8228D0AAQ36687719-B81D81C6-D323-43B4-AAB6-4395B455FD6DQ36688877-31A9C9E8-A7BB-43BE-86AB-200F38636215Q37267995-DD882CA5-2BEC-4161-9789-1A6D252547CEQ37492672-43B5DF17-CB8D-47AE-A895-2554094392C0Q37532508-7A6E77F4-6DC7-470E-A3E8-2B229CDEEE71Q37532512-29ECF417-80DA-48B1-8A89-B1D7B920DD45Q37586947-855EBFE9-CBC7-41D9-8C31-590E9BD769F5Q37979181-8EA6FEC2-8704-4C0E-AE47-B4A0EF45D1D6Q38107909-4FA30F95-1870-41A2-980D-27ADE76F43E9Q38868935-3EDCF3D0-9CFA-4CE6-89EF-81621E133263Q39769740-A77E1C1F-F126-4A9C-A6CD-F4CAA4FF4794Q42919512-D77EF90B-D716-4EF0-8046-834216CFD148Q46070437-824C8674-5EBA-485C-8579-D2B8AE316338Q46323805-69493184-6370-4B2D-AC27-F57342EFF3EDQ46375927-6B28F9CC-7885-4537-9782-4B5C1EE2E2B9Q49247169-31110B04-BE76-46A5-AE24-C74FE36CD42CQ50144854-C6C7781B-45EC-4A55-A6A8-72D19FFB0B72Q51699954-A2D492B0-5073-4E3A-80AF-BFFD25095406
P2860
The clinical use and immunologic impact of thrombin in surgery.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The clinical use and immunologic impact of thrombin in surgery.
@ast
The clinical use and immunologic impact of thrombin in surgery.
@en
type
label
The clinical use and immunologic impact of thrombin in surgery.
@ast
The clinical use and immunologic impact of thrombin in surgery.
@en
prefLabel
The clinical use and immunologic impact of thrombin in surgery.
@ast
The clinical use and immunologic impact of thrombin in surgery.
@en
P356
P1476
The clinical use and immunologic impact of thrombin in surgery.
@en
P2093
Jeffrey H Lawson
P304
P356
10.1055/S-2006-939559
P478
32 Suppl 1
P577
2006-04-01T00:00:00Z